ClinicalTrials.gg
RecruitingNCT07648316Updated Nov 6, 2026

Effects of Red Panax Ginseng Supplementation on Cognitive Performance and Emotional Well-Being in Young Healthy Adults

An interventional study of Ginseng and Placebo in Mental Acuity, sponsored by Arizona State University. Recruiting at 1 site in United States. Open to participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-06.

Sponsored by Arizona State University · Not applicable, Interventional, and Basic science

How we know

From the registry’s dates

  • Started Jun 2026; still recruiting 5 months later.
Updated Nov 6, 2026Now RecruitingFirst site in United States+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 30 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 654 studies in Psychological Well-Being with a site in United States — 187 open to participants now, 239 under way, 1 of them phase 3. Psychological Well-Being · United States.

Planned enrollment
476th of 572
30 · median 116
Started
2026
with 83 others
No phase
514 of 654
151 open now
Primary completion
2026-12
later than 71 of 237 live
Registered
618th of 654
by date

Among the 654 studies in Psychological Well-Being with a site in United States, this one is the 476th largest by planned enrollment of the 572 interventional ones that give a count, is one of 84 that started in 2026, is one of 514 with no phase, reaches primary completion later than 71 of the 237 other live ones, and was the 618th registered.

Psychological Well-Being

2,208 studies on the registry are indexed under Psychological Well-Being; 730 are open to participants now.

Browse Psychological Well-Being studies →

Open to participants now

187 of the 654 studies in Psychological Well-Being with a site in United States are open now. Recruiting first, the newest first:

181 more — sign in →

All 187 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 403 Psychological Well-Being studies recruiting now, 223 (55%) set no upper age limit and 155 (38%) stop at 75 or younger; 121 take children under 18; 206 take healthy volunteers.

This study: 18 Years to 30 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 654 studies in Psychological Well-Being with a site in United States, or all of them as a file.
02

Study summary

College students face substantial and persistent mental health challenges that directly affect cognitive performance, stress regulation, and emotional well-being. Neurological functions such as working memory, attention regulation, executive control, and emotional processing are highly sensitive to stressors, leaving young adults vulnerable to daily fluctuations in cognitive efficiency. Recent findings from the Healthy Minds Network (2025) indicate that although rates of moderate to severe depression among college students declined from 44% in 2022 to 37% in 2025, and anxiety symptoms fell from 37% to 32%, levels of psychological flourishing also dropped, falling to 36% despite these improvements.

Ginseng contains bioactive compounds known as ginsenosides that favorably influence brain function and inflammatory cascades. Studies in stressed and moderately stressed adults demonstrated reduced perceived stress, improved emotional processing, enhanced cognitive performance, and beneficial changes to biomarkers with ginseng supplementation. In addition, randomized controlled trials reported improvements in mood regulation, fatigue resistance, and aspects of working memory and attention following short-term ginseng supplementation. This study will examine the effects of daily red panax ginseng supplementation (3000 mg/day; two 1500 mg Red Panax gummies) on cognitive performance and emotional well-being in healthy young adults.

Read the detailed description

College students face substantial and persistent mental health challenges that directly affect cognitive performance, stress regulation, and emotional well-being. Neurological functions such as working memory, attention regulation, executive control, and emotional processing are highly sensitive to stressors, leaving young adults vulnerable to daily fluctuations in cognitive efficiency. Recent findings from the Healthy Minds Network (2025) indicate that although rates of moderate to severe depression among college students declined from 44% in 2022 to 37% in 2025, and anxiety symptoms fell from 37% to 32%, levels of psychological flourishing also dropped, falling to 36% despite these improvements.

Ginseng contains bioactive compounds known as ginsenosides that favorably influence multiple neurobiological pathways such as neurotrophic signaling, neurotransmitter regulation, oxidative balance, and inflammatory cascades. Studies in stressed and moderately stressed adults demonstrated reduced perceived stress, improved emotional processing, enhanced cognitive performance, and modulated biomarkers related to the hypothalamic-pituitary-adrenal axis with ginseng supplementation. In addition, randomized controlled trials reported improvements in mood regulation, fatigue resistance, and aspects of working memory and attention following short-term ginseng supplementation. This study will examine the effects of daily red panax ginseng supplementation (3000 mg/day; two 1500 mg Red Panax gummies) on cognitive performance and emotional well-being in healthy young adults.

03

Conditions studied

  • Mental Acuity

Keywords

  • ginseng
  • mental health
  • cognitive performancd
04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy young adults
  • 18-30 years of age

Exclusion criteria

Exclusion Criteria:

  • medication/drug use that has not been consistent for the previous 3 months or will be discontinued during the trial
  • unresolved chronic medical conditions (e.g., presence of persistent symptomology)
  • diagnosed clinical depression
  • acute illness
  • regular use of cigarettes or marijuana
  • pregnant or lactating women
  • not fluent in English
  • currently competing in sports or unusually high-intensity exercise protocols (e.g., high-intensity exercise greater than 30 minutes most days of the week)
  • current use of ginseng or adaptogenic supplements, or allergy to ginseng
  • any significant food allergies
  • not willing to attend two in-person lab visits in downtown Phoenix and follow study protocol (including abstaining from caffeine in the 12 hours prior to testing)
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    ginseng

    ginseng

    Dietary Supplement: Ginseng

  • Placebo comparator
    Placebo

    strawberry gummy (2)

    Dietary Supplement: Placebo

Interventions

  • Dietary supplementAsian ginsengStudies of Asian ginsengAsian ginseng pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.

    This study will test the efficacy of ginseng on health compared to placebo treatment.

  • Dietary supplementPlacebo

    This study will test the efficacy of ginseng on health compared to placebo treatment.

06

What researchers measure

Primary outcomes

  1. cognitive performance

    Trail Making Test: measures cognitive flexibility; visual attention, and executive function, with interpretation based on completion times (in seconds)

    Time frame: 2 hours post ingestion

  2. cognitive performance

    Trail Making Test measures cognitive flexibility; visual attention, and executive function, with interpretation based on completion times (in seconds)

    Time frame: 2 weeks

Secondary outcomes

  1. stress

    Perceived Stress Scale: higher scores indicate higher stress

    Time frame: 2 weeks

  2. mental well being

    Warwick-Edinburgh Mental Well-Being Scale: higher scores indicating greater positive mental wellbeing

    Time frame: 2 weeks

Other outcomes

  1. cognitive performance

    Stroop test: measures attention span, reaction time, and ability to resist distractions

    Time frame: 2 hours post ingestion

  2. cognitive performance

    reaction time test: measured by the elapsed time between stimulus onset and an individual's response

    Time frame: 2 hours post ingestion

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2026 (actual). Primary completion is estimated for Dec 2026, 5 months after the start.

Of 1,274 non-industry interventional studies with no phase under Psychological Well-Being, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 34. This study's planned 5 months is below that.

Counting every sponsor, half of 1,317 studies reached it within 16 months; a quarter within 7 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 10, 2026
First posted
Jun 15, 2026
StartActual
Jun 22, 2026
Primary completionEst.
Dec 15, 2026
CompletionEst.
Jun 15, 2027
Last update
Nov 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Nov 6, 2026
Sites
1 site added — first site in United States
Show site
  • Health North ASU Downtown Campus · Phoenix, United States
Nov 6, 2026
Show all 1 update
  1. Nov 6, 2026
    Not yet recruiting→Recruiting
    1 site added — first site in United States
    Show site
    • Health North ASU Downtown Campus · Phoenix, United States
    + 1 other change: date precision

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07648316
Responsible party
Carol Johnston (Professor and Senior Associate Dean, Arizona State University) — Principal investigator
First posted
Jun 15, 2026
Start date
Jun 22, 2026
Primary completion
Dec 15, 2026 (estimated)
Completion
Jun 15, 2027 (estimated)
Last update
Nov 6, 2026

Study contacts

Carol Johnston
Contact
carol.johnston@asu.edu
6024963463
Carol Johnston
principal investigator · Arizona State University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Asian ginseng

Start the discussion